https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Benefits and harms of prostate specific antigen testing according to Australian guidelines https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53768 Wed 28 Feb 2024 15:52:43 AEDT ]]> Improving colonoscopy prioritisation and promoting the National Bowel Cancer Screening Program: keys to reducing bowel cancer burden https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52608 Wed 18 Oct 2023 13:38:22 AEDT ]]> Contrasting temporal trends in lung cancer incidence by socioeconomic status among women in New South Wales, Australia, 1985-2009 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34080 Wed 06 Feb 2019 14:24:26 AEDT ]]> Widening socioeconomic disparity in lung cancer incidence among men in New South Wales, Australia, 1987-2011 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33631 Wed 06 Apr 2022 13:58:13 AEST ]]> Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48997 35 cigarettes/day. Lung cancer risk was lower with quitting at any age but remained higher than never-smokers for quitters aged >25y. By age 80y, an estimated 48.3% of current-smokers (41.1% never-smokers) will develop cancer, and 14% will develop lung cancer, including 7.7% currently smoking 1-5 cigarettes/day and 26.4% for >35 cigarettes/day (1.0% never-smokers). Cancer risk for Australian smokers is significant, even for 'light' smokers. These contemporary estimates underpin the need for continued investment in strategies to prevent smoking uptake and facilitate cessation, which remain key to reducing cancer morbidity and mortality worldwide.]]> Wed 03 May 2023 12:03:16 AEST ]]>